A role for proliferative measurements in clinical oncology?
I feel a simple but properly determined proliferative measurement is within our grasp for clinical use. In addition, multi-parametric flow cytometry offers a means of obtaining more detailed cell kinetic information, using DNA staining combined with staining with one or more antibodies directed against either BrdUrd or proliferation-related proteins.
Camplejohn
R
R
D001943:Breast Neoplasms / Q000473:pathology; D002455:Cell Division / Q000502:physiology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007700:Kinetics; D009369:Neoplasms / Q000473:pathology*